MONTELUKE AB : Available on Steris Healthcare PVT LTD

MONTELUKE AB

Montelukast (10mg), Acebrophylline SR (200mg)

MONTELUKE AB is a combination medication that includes Montelukast at a strength of 10mg and Acebrophylline sustained-release (SR) at a strength of 200mg. This combination is commonly prescribed for the management of asthma and chronic obstructive pulmonary disease (COPD). This comprehensive guide explores its uses, dosage, side effects, price, composition, and more.

Uses:

1. Asthma Management: MONTELUKE AB is primarily used as maintenance therapy to control asthma symptoms and prevent asthma attacks in both adults and children.
2. COPD Treatment: It may also be prescribed as adjunct therapy in chronic obstructive pulmonary disease (COPD) to improve lung function and reduce exacerbations.
3. Anti-inflammatory and Bronchodilator Effects: Montelukast works by blocking leukotrienes, substances in the body that contribute to inflammation and bronchoconstriction, while Acebrophylline acts as a bronchodilator and mucoregulator, reducing airway resistance and enhancing mucus clearance.

Dosage:

• Initial Dose: The typical starting dose of MONTELUKE AB is one tablet containing Montelukast 10mg and Acebrophylline SR 200mg once daily.
• Titration: Depending on the patient's response and symptom control, the dose may be adjusted under medical supervision.
• Administration: It is usually taken orally with water, preferably before meals.

Side Effects:

While generally well-tolerated, MONTELUKE AB may cause some side effects, including:

• Gastrointestinal Disturbances: Common side effects may include nausea, vomiting, abdominal discomfort, or diarrhea.
• Headache: Some individuals may experience headaches, which are usually mild and transient.
• Allergic Reactions: Rarely, allergic reactions such as skin rash, itching, or swelling may occur and require medical attention.
• Other Side Effects: Additional potential side effects may include dizziness, fatigue, mood changes, and muscle or joint pain.

Price and Availability:

The price of MONTELUKE AB can vary based on factors such as the brand, dosage strength, and the number of tablets per pack. It is generally available at pharmacies with a prescription from a healthcare provider.

Composition:

Each MONTELUKE AB tablet contains Montelukast Sodium equivalent to Montelukast 10mg and Acebrophylline sustained-release (SR) at a strength of 200mg. Montelukast is a leukotriene receptor antagonist, while Acebrophylline is a combination of theophylline and ambroxol, acting as a bronchodilator and mucoregulator.

Precautions:

• Pregnancy and Lactation: MONTELUKE AB should be used with caution during pregnancy and breastfeeding, and its benefits should outweigh potential risks.
• Liver or Kidney Impairment: Dose adjustments may be necessary in patients with impaired liver or kidney function, and close monitoring is recommended.
• Drug Interactions: MONTELUKE AB may interact with other medications, such as theophylline, erythromycin, and certain antifungal agents, requiring dose adjustments or monitoring for adverse effects.

Interactions:

MONTELUKE AB may interact with other medications, such as:

• Theophylline: Concurrent use with theophylline may increase the risk of theophylline toxicity, necessitating dose adjustments and monitoring.
• Erythromycin: Erythromycin may increase Montelukast levels in the blood, requiring dose adjustments or monitoring for adverse effects.
• Antifungal Agents: Some antifungal agents may interact with Montelukast, potentially affecting its efficacy or safety profile.

Conclusion:

MONTELUKE AB, combining Montelukast 10mg and Acebrophylline SR 200mg, is an effective combination therapy for the management of asthma and chronic obstructive pulmonary disease (COPD). Its dual action on inflammation and airway function provides comprehensive symptom control. However, cautious use, adherence to prescribed doses, and regular monitoring for side effects and interactions are essential for optimal safety and effectiveness. Patients should consult their healthcare providers for personalized guidance and management. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology.The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW